Table 3.
Summary of the solicited treatment emergent adverse events (TEAEs) reported at least once by 37 patients
| TEAEs (% of patients) | Possibly or probably drug-related TEAEs (% of patients) | |||||
|---|---|---|---|---|---|---|
| Description | FD ASAQ | NF ASAQ | All | FD ASAQ | NF ASAQ | All |
| (N = 26) | (N = 28) | (N = 54) | (N = 26) | (N = 28) | (N = 54) | |
| At least one TEAE | 18 (69.2) | 19 (67.9) | 37 (68.5) | 5 (19.2) | 5 (17.9) | 10 (18.5) |
| Headache | 10 (38.5) | 12 (42.9) | 22 (40.7) | - | - | - |
| Weakness | 8 (30.8) | 11 (39.3) | 19 (35.2) | - | 2 (7.1) | 2 (3.7) |
| Anorexia | 7 (26.9) | 7 (25.0) | 14 (25.9) | 1 (3.8) | - | 1 (1.9) |
| Nausea | 6 (23.1) | 8 (28.6) | 14 (25.9) | - | - | - |
| Abdominal pain | 6 (23.1) | 7 (25.0) | 13 (24.1) | 1 (3.8) | 1 (3.6) | 2 (3.7) |
| Itching | 6 (23.1) | 3 (10.7) | 9 (16.7) | 3 (11.5) | 2 (7.1) | 5 (9.3) |
| Vomiting | 4 (15.4) | 2 (7.1) | 6 (11.1) | - | - | - |
| Diarrhoea | 2 (7.7) | 2 (7.1) | 4 (7.4) | - | 1 (3.6) | 1 (1.9) |
| Rhinitis | 2 (7.7) | 2 (7.1) | 4 (7.4) | 1 (3.8) | - | 1 (1.9) |
| Cough | 1 (3.8) | 2 (7.1) | 3 (5.6) | - | - | - |
All FD vs NF ASAQ comparisons were not statistically significant.